News

Pharmabiz22h
KPRDO concerned over JAKs selling other branded generic drugs in violation of Clause 2.4 of PMBI agreement
Nandita Vijayasimha, Bengaluru Tuesday, July 29, 2025, 08:00 Hrs [IST] ...
Pharmabiz13h
Elpis Biopharma inks MoU with National Cancer Centre Singapore to conduct translational cell therapy research in Singapore
Elpis Biopharma inks MoU with National Cancer Centre Singapore to conduct translational cell therapy research in Singapore: Singapore Tuesday, July 29, 2025, 17:00 Hrs [IST] Elpis ...
Pharmabiz14h
Akeso announces China NMPA accepts sNDA for ivonescimab in combo with chemotherapy to treat advanced squamous NSCLC
Akeso announces China NMPA accepts sNDA for ivonescimab in combo with chemotherapy to treat advanced squamous NSCLC: Honk Kong Tuesday, July 29, 2025, 16:00 Hrs [IST] Akeso, Inc., ...
Pharmabiz17h
Tata Elxsi & KAVIA AI ink strategic pact, bringing GenAI powered SDLC automation to healthcare enterprises among others
Tata Elxsi & KAVIA AI ink strategic pact, bringing GenAI powered SDLC automation to healthcare enterprises among others: Our Bureau, Bengaluru Tuesday, July 29, 2025, 12:30 Hrs [I ...
Pharmabiz15h
Biocon Foundation and IISc on World Head & Neck Cancer Day called for oral cancer elimination
Biocon Foundation and IISc on World Head & Neck Cancer Day called for oral cancer elimination: Our Bureau, Bengaluru Tuesday, July 29, 2025, 14:50 Hrs [IST] Biocon Foundation, the ...
Pharmabiz14h
BPL Medical Technologies chief notes inking India-UK FTA to propel growth
BPL Medical Technologies chief notes inking India-UK FTA to propel growth: Our Bureau, Bengaluru Tuesday, July 29, 2025, 15:30 Hrs [IST] BPL Medical Technologies managing director ...
Pharmabiz13h
Fortis and Agilus expand rapid genomic testing capabilities with launch of second Genexus System
Fortis and Agilus expand rapid genomic testing capabilities with launch of second Genexus System: Our Bureau, Bengaluru Tuesday, July 29, 2025, 16:15 Hrs [IST] Fortis Memorial Res ...
Pharmabiz16h
Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat
Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat: New Taipei City Tuesday, July 29, 2025, 14:00 Hrs [I ...
Pharmabiz18h
Hengrui Pharma enters agreement and with GSK to develop up to 12 innovative medicines across respiratory, immunology & inflammation & oncology
Hengrui Pharma enters agreement and with GSK to develop up to 12 innovative medicines across respiratory, immunology & inflammation & oncology: Jiangsu, China Tuesday, July 29, 20 ...
Pharmabiz22h
CDSCO introduces QR Code for visitors to fill before visiting its headquarters
CDSCO introduces QR Code for visitors to fill before visiting its headquarters: Gireesh Babu, New Delhi Tuesday, July 29, 2025, 08:00 Hrs [IST] As part of simplifying and streamli ...
Pharmabiz17h
China NMPA accepts for review Bayer’s NDA for sevabertinib to treat adult patients with advanced non-small cell lung cancer NSCLC
China NMPA accepts for review Bayer’s NDA for sevabertinib to treat adult patients with advanced non-small cell lung cancer NSCLC: Berlin Tuesday, July 29, 2025, 13:00 Hrs [IST] ...
Pharmabiz14h
Cryoviva launches stem cell collection services in the Philippines
Cryoviva launches stem cell collection services in the Philippines: Our Bureau, Bengaluru Tuesday, July 29, 2025, 15:45 Hrs [IST] Cryoviva Lifesciences in the area of stem cell ba ...